Citizens Financial Group, East West Bancorp, and Wintrust Financial are regional banks that could see increases in stock price. Citizens
Tyson Foods Inc. (NYSE:TSN) is under the spotlight with media reports attributing flat year-to-date shares to various factors, including a
GE Vernova Inc. (NYSE:GEV) is an industrial machinery firm that has seen a 95% increase in shares year-to-date, with a
Li Auto Inc. reported delivering 44,246 vehicles in December 2025, bringing the fourth-quarter total to 109,194 units. By the end
Despite some detractors, Amazon (NASDAQ: AMZN) remains a top holding for many investors, with a strong track record of success.
Fluor’s stock underperformed the S&P 500 in 2025, declining 20% while the S&P 500 rose 17%. The company faced challenges
Indian shares saw a slight increase with the BSE Sensex up 140 points and NSE Nifty up 42 points in
FOX (FOXA) has a 19.7% GAAP Operating Margin but faces challenges with revenue growth and returns on capital. Deckers (DECK)
Semiconductor stocks have seen a 32.6% gain in the last six months, outperforming the S&P 500 by 21.3 percentage points.
Indian shares are expected to open slightly higher after a positive end to 2025. Vehicle sales data and Q3 updates
The price of silver soared in 2025, hitting an all-time high above $80 before dropping 10% on Dec. 29. The
Society Pass Incorporated (Nasdaq: SOPA) closed a public offering of 1,500,000 shares at $2.00 per share, raising $3 million. Rodman
VS Media Holdings Limited (VSME) plans to implement a 1-for-20 share combination of its Class A and Class B ordinary
The stock market is currently trading at a high valuation, with three consecutive years of strong gains, leading to concerns
TAP Real Estate Technologies, Inc. (formerly known as HUMBL, Inc.) is shifting its focus to real estate asset acquisition and
In a market focused on growth stocks, high-yield dividend stocks offer stability and income. Here are three trusted dividend stocks
Xeris Biopharma (NASDAQ: XERS) saw a more than 7% price gain after a competitor’s FDA setback. Corcept Therapeutics’ relacorilant medication
Prime Drink Group Corp. (CSE: PRME) has closed the first part of its private placement offering, raising $450,000. The company
XORTX Therapeutics Inc. highlights recent research linking genetic factors to gout and high uric acid levels, supporting their approach to
Light New Year’s Eve trading saw a late-December pullback, with the S&P 500 falling 0.74%, Nasdaq Composite losing 0.76%, and
Parkit Enterprise Inc. issued 1,371,000 options to directors, officers, employees, and consultants, exercisable at $0.56 per share within ten years
Amplify Energy Corp. (NYSE: AMPY) closed an amended revolving credit facility with Citizens Bank, N.A., extending the maturity to December
Intelligent Bio Solutions Inc. (INBS) announced a private placement with institutional investors for approximately $10.0 million. The placement includes shares
Corcept Therapeutics (NASDAQ:CORT) shares plummeted 51.4% after the FDA rejected their New Drug Application for relacorilant, a hypertension treatment for
TC Energy Corporation announced that it will not redeem its Cumulative Redeemable First Preferred Shares, Series 5 and Series 6
